Mobile Health-based Motivational Interviewing for Vaccine Hesitancy
(COVID-19 Trial)
Recruiting at 1 trial location
AB
TB
Overseen ByThanh Bui
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Oklahoma State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The objective of this study is to evaluate the preliminary efficacy and acceptability of an mobile Health-based motivational interviewing (MI) intervention to promote SARS-CoV-2 vaccination (MOTIVACC) compared to traditional phone-based MI.
Eligibility Criteria
This trial is for adults over 18 living in rural areas who haven't had a COVID-19 vaccine and can speak English. They must be able to consent and use a smartphone. It's not for those with certain medical/psychiatric conditions, involved in other COVID studies, or pregnant/lactating women.Inclusion Criteria
Reside in a rural area
No previous dose of a SARS-CoV-2 vaccine
Able to provide informed consent
Exclusion Criteria
Inability to participate because of medical or psychiatric conditions diagnosed by a physician/clinician
Pregnant or lactating
You have a condition that makes it difficult for you to use a smartphone or affects your thinking ability.
See 1 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Intervention
Participants receive mobile Health-based motivational interviewing (MI) intervention to promote SARS-CoV-2 vaccination
4-6 weeks
Follow-up
Participants are monitored for vaccination uptake and intervention effectiveness
4 weeks
Treatment Details
Interventions
- MOTIVACC
Trial Overview The study tests if mobile Health-based motivational interviewing (MOTIVACC) encourages people to get vaccinated against COVID-19 more effectively than traditional phone calls. Participants will receive different types of motivational messages.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Standard MIExperimental Treatment2 Interventions
Group II: MOTIVACCExperimental Treatment2 Interventions
Group III: Intensive MIExperimental Treatment2 Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oklahoma State University
Lead Sponsor
Trials
51
Recruited
8,600+
University of Oklahoma
Collaborator
Trials
484
Recruited
95,900+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.